Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             35 results found
no title author magazine year volume issue page(s) type
1 Adherence to surveillance guidelines in resected NSCLC: Physician compliance and impact on outcomes Ho, Cheryl
2017
112 C p. 176-180
article
2 Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis Nishie, Kenichi
2017
112 C p. 25-34
article
3 Anaplastic lymphoma kinase gene rearrangement predicts better prognosis in NSCLC patients: A meta-analysis Wang, Zili
2017
112 C p. 1-9
article
4 A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202 Kuyama, Shoichi
2017
112 C p. 188-194
article
5 Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy Aggarwal, Charu
2017
112 C p. 118-125
article
6 Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry Lara, Joshua D.
2017
112 C p. 165-168
article
7 Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancer Tomizawa, Kenji
2017
112 C p. 57-61
article
8 Contents 2017
112 C p. iv-vi
article
9 Corrigendum to: ‘Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan’ [Lung Cancer 46 (November(2)) (2004) 165–170] Cheng, Ya-Wen
2017
112 C p. 232-233
article
10 Does timeliness of care in Non-Small Cell Lung Cancer impact on survival? Vinod, Shalini K.
2017
112 C p. 16-24
article
11 Editorial Board 2017
112 C p. iii
article
12 Fine-mapping the MHC region in Asian populations identified novel variants modifying susceptibility to lung cancer Qin, Na
2017
112 C p. 169-175
article
13 Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation Hsieh, Feng-Shu
2017
112 C p. 81-89
article
14 Limited mutagenicity of electronic cigarettes in mouse or human cells in vitro Tommasi, Stella
2017
112 C p. 41-46
article
15 LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value Facchinetti, Francesco
2017
112 C p. 62-68
article
16 Marked response to pembrolizumab in a patient with pulmonary pleomorphic carcinoma highly positive for PD-L1 Ikematsu, Yuki
2017
112 C p. 230-231
article
17 MHC class II expression in lung cancer He, Yayi
2017
112 C p. 75-80
article
18 Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis Liu, Jian
2017
112 C p. 47-56
article
19 Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases Kwint, Margriet
2017
112 C p. 134-139
article
20 Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer Reck, Martin
2017
112 C p. 181-187
article
21 Patterns of care and survival among patients with malignant mesothelioma in the United States Enewold, Lindsey
2017
112 C p. 102-108
article
22 PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review Brody, Robert
2017
112 C p. 200-215
article
23 Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers Yu, Helena A.
2017
112 C p. 195-199
article
24 Phenotypes of lung cancer and statistical interactions between tobacco smoking and occupational exposure to asbestos and crystalline silica from a large case-only study: The CaProMat study El Zoghbi, Mohamad
2017
112 C p. 140-155
article
25 PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort Sawa, Kenji
2017
112 C p. 96-101
article
26 Plasma concentration of osimertinib in a non-small cell lung cancer patient with chronic renal failure undergoing hemodialysis Tamura, Tomohiro
2017
112 C p. 225-226
article
27 Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients Mezquita, Laura
2017
112 C p. 10-15
article
28 Prospective analysis of patient reported symptoms and quality of life in patients with incurable lung cancer treated in a rapid access clinic Lefresne, Shilo
2017
112 C p. 35-40
article
29 Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer Schvartsman, Gustavo
2017
112 C p. 90-95
article
30 Serum lipid profile discriminates patients with early lung cancer from healthy controls Ros-Mazurczyk, Małgorzata
2017
112 C p. 69-74
article
31 The establishing of a new thoracic surgery department in Greece in the era of financial crisis Kapetanakis, Emmanouil I.
2017
112 C p. 227-229
article
32 Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review Jacobsen, Margo M.
2017
112 C p. 156-164
article
33 Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer – final results from the prospective German TLK cohort study von Verschuer, Ulla
2017
112 C p. 216-224
article
34 Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer Paz-Ares, Luis G.
2017
112 C p. 126-133
article
35 Wolf in Sheep’s Clothing: Primary Lung Cancer Mimicking Benign Entities Snoeckx, Annemie
2017
112 C p. 109-117
article
                             35 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands